Non-exclusive voluntary licensing outside of HIV/AIDS

Bristol-Myers Squibb, Gilead
Gilead and Bristol-Myers Squibb take the first moves, from companies in scope of the Access to Medicine Index 2016, outside non-exclusive voluntary licensing in HIV/AIDS.
Continue reading

Hepatitis C virus elimination programme

Gilead
Gilead launched an innovative donation programme with the goal of eliminating hepatitis C virus in Georgia.
Continue reading

Publishing the registration status of products, country-by-country

Gilead
Gilead publishes where it has filed for specific products to be registered, and when filings were successful.
Continue reading

Regional Business Partner Compliance Pocket Guide

Gilead
The Regional Business Partner Compliance Pocket Guide is a guide to support compliance by third parties working with Gilead.
Continue reading

Non-exclusive voluntary licensing to support affordability and supply

Gilead
Gilead’s early, systematic approach towards non-exclusive voluntary licensing helps efficient scale up and affordable supply of patented medicines in low- and middle-income countries.
Continue reading